Neurable Raises $35 Million Series A to Accelerate Deployment of Everyday Brain-Computer Interface Technology

BOSTON--(BUSINESS WIRE)--Neurable, the leader in noninvasive brain-computer interface (BCI) technology designed for everyday life, today announced it has closed a $35 million Series A round to accelerate the commercialization of Neurable AI, the company’s patented compact brain-signal processing technology that seamlessly integrates BCI capabilities into the devices people already use every day. This brings the company’s total funds raised to $65 million.

The round, led by Spectrum Moonshot Fund, fuels Neurable’s next stage of growth as the company brings advanced neurotechnology out of the lab and into daily routines, making brain insights as accessible as heart-rate or sleep tracking. Neurable recently introduced the MW75 Neuro LT, along with a newly updated app that provides real-time cognitive insights on mental fatigue, cognitive recovery, and focus state detection. Powered by Neurable AI, these capabilities have been validated across multiple independent evaluations and peer-reviewed studies, demonstrating the system’s ability to detect focus, distraction, and cognitive state changes with high fidelity.

“Our mission is to make understanding your brain as natural and intuitive as checking your steps,” said Dr. Ramses Alcaide, CEO and Co-Founder of Neurable. “With the MW75 Neuro LT and the redesigned Neurable app, people can finally see how their mind performs throughout the day. This funding allows us to scale Neurable AI into new devices and new industries, making cognitive health an accessible, daily utility for everyone.”

Investor confidence reflects the accelerating shift toward brain-centric wellness and performance tools. “We invested in Neurable because the team has achieved something remarkable: bringing high-quality BCI technology into an elegant consumer product powered by outstanding signal-processing algorithms,” said Mauro Guebeli, Investment Manager at Spectrum Value Management. “We believe this is only the beginning and that this highly motivated team is well positioned to build a powerful platform in this emerging space.”

Existing investors also reaffirmed their support. “We view Neurable as a leader in translating deep scientific breakthroughs into an effective, accessible, and desirable consumer product that can harness the power of the human brain for more conscious and healthier lives,” said Marius Swart, Managing Partner at Pace Ventures.

With the Series A funding, Neurable will expand its neurotechnology platform across the broader cognitive health and human performance ecosystem. One major focus area is gaming and e-sports, where even small gains in concentration, reaction time, and cognitive endurance can significantly impact competitive outcomes.

“Gaming is one of the most immediate and intuitive applications of Neurable AI,” said Adam Molnar, Co-Founder and VP of Strategic Partnerships at Neurable. “Players are constantly pushing their cognitive limits. By integrating brain insights directly into gaming workflows and devices, we’re opening a new frontier in player performance and game design.”

Beyond gaming, the company continues to strengthen its position within research applications and emerging BCI-enabled product categories. Neurable recently partnered with iMotions, the world’s leading human behavior research platform, integrating Neurable’s headsets into its software suite and enabling researchers and product teams to capture high-quality neural data at scale. It also collaborated with MeSpace to investigate how adaptive workstations affect cognitive performance.

As the BCI market is expected to exceed $52 billion globally by 2034, Neurable’s momentum signals a broader shift: brain data is becoming a foundational layer in how people work, play, and care for their well-being. Neurable aims to lead that transition with tools that make brain understanding intuitive, ethical, and available to everyone.

About Neurable Inc.

Neurable Inc. is a Massachusetts-based neurotechnology company that specializes in the development of AI-powered tools for brain signal translation and brain-computer interface technology. Powered by patented signal processing, developed through decades of pioneering research across leading labs and institutions, and advanced by a leading scientific and expert product team, the Neurable AI platform enables high-performance brain-computer interface in everyday devices. Neurable is dedicated to creating a world where individuals can overcome physical and mental limitations through innovative neurotechnology solutions. Learn more about Neurable at neurable.com.